| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −1.0× | −1.8× | |
| Price / Book | 2.7× | 2.1× | |
| Price / Sales | 3.8× | 4.0× | |
| Price / Free cash flow | −1.2× | −1.6× | |
| EV / EBITDA | −0.7× | −1.2× | |
| Earnings yield | −105.0% | −14.0% | |
| Free cash flow yield | −85.4% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,278.66 | −2.15% | $1.2T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.63 | −1.49% | $634.64B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.89 | −0.46% | $501.67B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $421.76 | −0.76% | $378.57B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.21 | −2.06% | $355.78B | 19.9× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $154.97 | −0.83% | $279.25B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $169.81 | −1.60% | $263.35B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $668.03 | −1.26% | $247B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $440.41 | −1.54% | $238.1B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.25 | −0.60% | $193.74B | 22.9× | 37.5% | +26.7% |
